Careers Contact Locations

OPKO Health, Inc.

  • Home
  • Who We Are
    • Our Vision
    • Our History
    • Our Leadership
  • What We Do
    • Overview
    • Our Products
    • Our Solutions
    • Our Technology
    • Our Research
    • Our Diagnostics
  • News & Media
    • Press Releases
    • Announcements
    • Events
    • Presentations
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact
  • Locations

Press Releases

News & Media

News & Media

  • Press Releases
  • Announcements
  • Events
  • Presentations

OPKO Health Announces Listing in Major Indices on Tel Aviv Stock Exchange

Aug 28, 2013

OPKO Health Announces New Listing on Tel Aviv Stock Exchange

Aug 19, 2013

OPKO Surpasses 50% Enrollment in Second Phase 3 Trial of Rayaldy™

Aug 15, 2013

OPKO Announces Second Quarter 2013 Operating and Financial Highlights

Aug 9, 2013

OPKO’s Citicoline Products Approved for Commercialization in Spain

Jul 24, 2013

OPKO Health Announces Appointment of David Okrongly, Ph.D. as President of its Diagnostics Business Unit

Jul 16, 2013

OPKO Health to Present at the Jefferies 2013 Global Healthcare Conference

May 30, 2013

OPKO Surpasses 50% Enrollment in First Phase 3 Trial of RayaldyTM (CTAP101 Capsules)

May 23, 2013

OPKO Announces First Quarter 2013 Operating and Financial Highlights

May 9, 2013

OPKO Health Acquires Interest in Growing Russian Pharmaceutical Company

Apr 18, 2013
RSS
  • Prev
    • 1...
    • 31
    • 32
    • 33
    • 34
    • 35
    • 36
    • 37
    • 38
    • 39
    • 40
    • ...47
    Next

    OPKO HEALTH, INC.
    4400 Biscayne Boulevard
    Miami, FL 33137

    305-575-4100
    contact@opko.com

    © 2023 OPKO Health, Inc. All Rights Reserved.
    Privacy Policy Governance Terms of Use Sitemap